Research dossier

SLU-PP-332 — pan-ERR agonism dossier

A small-molecule ERR agonist — not a peptide, and analytically different.

6 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

SLU-PP-332 — research dossier illustration

Molecular identity

ParameterValue
CAS number303760-60-3
Molar mass290.32 g/mol
Molecular formulaC₁₈H₁₄N₂O₂
Purity≥99%
AppearanceWhite lyophilised powder

The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.

Research context

Orphan nuclear receptors are a field in which classical pharmacology applies poorly, for want of an identified endogenous ligand. Synthetic agonists such as this one are the tools that make these receptors experimentally approachable, which explains the attention paid to this class.

Mechanism studied

SLU-PP-332 is not a peptide but a synthetic small molecule, which has direct consequences for its handling and its analytical control.

Its described target is the ERR family (estrogen-related receptors), orphan nuclear receptors comprising the α, β and γ isoforms. Despite their name and their sequence homology with the oestrogen receptors, the ERRs do not bind oestrogens: they are constitutively active receptors whose activity is governed mainly by the availability of coactivators, foremost among them PGC-1α.

The compound is described as a pan-ERR agonist, that is, active at all three isoforms. The published in-vitro work concerns transcription reporter assays in cell lines, measurement of the expression of oxidative metabolism target genes by RT-qPCR, and respirometry in cultured myotubes.

In-vitro literature

The literature is recent and limited. Transcription reporter assays are the measurement standard for this class of nuclear receptors.

Bibliographic entry points

These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.

Distinguishing this compound from its analogues

The ERRs do not bind oestrogens despite their name and their sequence homology. Do not transfer data from the oestrogen receptors.

The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.

Methodological limits

A small molecule with limited aqueous solubility: the final concentration of organic solvent must be controlled and a vehicle arm is indispensable, failing which the effect of the solvent is confounded with that of the compound. The literature is recent and independent replication still limited.

These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.

Analytical parameters

A small molecule: the purity criteria and chromatographic methods differ from those for peptides. Solubility in aqueous media is limited and generally requires an organic solvent, whose final concentration must be controlled in culture.

ParameterValue
StorageStore at −20 °C, protected from light
SolubilitySoluble in bacteriostatic water (BAC)
StabilityStable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C
Control methodsRP-HPLC · MS · NMR

Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.

Resulting concentrations

The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.

Format1 ml2 ml3 ml
5mg5.00 mg/ml2.50 mg/ml1.67 mg/ml

These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.

Protocol design

Three points govern the validity of an assay using this material, whatever the question being asked.

The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.

The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.

The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.

Lot verification

The following formats are covered by a Janoshik Analytical report, readable from the product page:

  • 5mg — lot report available
FormatLot reportAvailability
5mgCoveredIndisponible

The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.

Frequently asked questions

How does this product arrive?

As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.

Which solvent should be used for reconstitution?

Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.

How long does the material remain stable?

The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.

Does the analysis report correspond exactly to my vial?

The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.

Can this product be used on humans or animals?

No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.

Dossiers in the same category

Related dossiers

All research dossiers → · Catalogue → · Glossary →